Bourgeois Blaise F D
Division of Epilepsy & Clinical Neurophysiology, Children's Hospital, Boston, MA 02115, USA.
J Child Neurol. 2002 Feb;17 Suppl 2:2S28-2S33. doi: 10.1177/08830738020170020901.
As a group, children and adolescents with epilepsy have a higher prevalence of cognitive and behavioral disorders, although many fall within the normal distribution. For those affected, several causes have been identified, some of which may be interrelated. It has proven to be methodologically sound to isolate the role of specific antiepileptic drugs as a cause of cognitive impairment. The large body of literature that has accumulated on this topic is characterized by a relatively high proportion of inconclusive or contradictory observations. This may be due in part to the many methodological pitfalls in this area of research. The emerging picture is that cognitive effects caused by antiepileptic drugs are neither the rule nor the exception. Although certain drugs appear more likely to be involved, no single drug causes problems in every patient, and no drug can be assumed never to cause any cognitive impairment. The subgroup of patients that are at higher risk cannot be easily defined. Early detection of cognitive effects is based on actively eliciting reports of symptoms. This can be complemented by a screening battery in case of suspicion.
总体而言,癫痫患儿和青少年认知及行为障碍的患病率较高,尽管许多人处于正常分布范围内。对于那些受影响的人,已经确定了几个原因,其中一些可能相互关联。事实证明,将特定抗癫痫药物的作用作为认知障碍的一个原因分离出来在方法上是合理的。关于这个主题积累的大量文献的特点是,不确定或相互矛盾的观察结果比例相对较高。这可能部分归因于该研究领域存在的许多方法缺陷。新出现的情况是,抗癫痫药物引起的认知影响既不是普遍规律,也不是个别现象。虽然某些药物似乎更有可能涉及其中,但没有一种药物会在每个患者身上都引发问题,也不能假定任何药物永远不会导致任何认知障碍。高风险患者亚组不容易界定。认知影响的早期检测基于积极询问症状报告。如有怀疑,可通过一套筛查测试加以补充。